Voyager Therapeutics Inc Stock
Voyager Therapeutics Inc Stock
Voyager Therapeutics Inc dominated the market today, gaining €0.31 (4.410%).
Currently there is a rather positive sentiment for Voyager Therapeutics Inc with 3 Buy predictions and 0 Sell predictions.
With a target price of 16 € there is potential for a 124.56% increase which would mean more than doubling the current price of 7.13 € for Voyager Therapeutics Inc.
Our community identified positive and negative aspects for Voyager Therapeutics Inc stock for the coming years. 2 users see the criterium "Worthwhile Investment for the next years" as a plus for the Voyager Therapeutics Inc stock. On the other hand our users think that "General Risks" could be a problem in the future.
Pros and Cons of Voyager Therapeutics Inc in the next few years
Pros
?
B****
?
M***** P*******
?
S********** s********
Cons
?
G***** c******* t* c**********
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Voyager Therapeutics Inc vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Voyager Therapeutics Inc | 4.410% | -1.656% | -16.667% | 4.015% | -10.377% | 58.052% | - |
| Ardelyx Inc. | 3.600% | -1.640% | -12.849% | 41.749% | 3.737% | -16.140% | - |
| Salarius Pharmaceuticals Inc. | 1.400% | 3.333% | 6.373% | -63.833% | -21.802% | -98.281% | -99.993% |
| Brainstorm Cell | -5.760% | -2.456% | -18.607% | -82.011% | 114.009% | -83.339% | - |
News
Voyager Therapeutics stock pops 30% on deal with Novartis
Voyager Therapeutics Inc. (NASDAQ: VYGR) is a biotech in the medical sector that specializes in gene therapy for neurological diseases. Its shares took a 30% spike on news of its partnership with
